The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase
Open accessAbstract
BACKGROUND: There is growing awareness that tumour cells build up a "self-advantageous" microenvironment that reduces effectiveness of anti-tumour immune response. While many different immunosuppressive mechanisms are likely to come into play, recent evidence suggests that extracellular adenosine acting at A2A receptors may have a major role in down-modulating the immune response as cancerous tissues contain elevated levels of adenosine and adenosine break-down products. While there is no doubt that all cells possess plasma membrane adenosine transporters that mediate adenosine uptake and may also allow its release, it is now clear that most of extracellularly-generated adenosine originates from the catabolism of extracellular ATP. METHODOLOGY/PRINCIPAL FINDINGS: Measurement of extracellular ATP is generally performed in cell supernatants by HPLC or soluble luciferin-luciferase assay, thus it generally turns out to be laborious and inaccurate. We have engineered a chimeric plasma membrane-targeted luciferase that allows in vivo real-time imaging of extracellular ATP. With this novel probe we have measured the ATP concentration within the tumour microenvironment of several experimentally-induced tumours. CONCLUSIONS/SIGNIFICANCE: Our results show that ATP in the tumour interstitium is in the hundreds micromolar range, while it is basically undetectable in healthy tissues. Here we show that a chimeric plasma membrane-targeted luciferase allows in vivo detection of high extracellular ATP concentration at tumour sites. On the contrary, tumour-free tissues show undetectable extracellular ATP levels. Extracellular ATP may be crucial for the tumour not only as a stimulus for growth but also as a source of an immunosuppressive agent such as adenosine. Our approach offers a new tool for the investigation of the biochemical composition of tumour milieu and for development of novel therapies based on the modulation of extracellular purine-based signalling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, in a disease state as infection or brain disease, extracellular ATP levels largely increase and activate P2X7 receptors [68–70].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D. J., Usheva, A., Erat, A., Chen, J., Enjyoji, K., Linden, J. M., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,613
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,253
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
A2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D. E., Wong, M. K. K., Huang, X., Caldwell, S. A., Liu, K., Smith, P. T., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,095
The tumour microenvironment as a target for chemoprevention
Albini, A., & Sporn, M. B. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2067 · Cited by 828
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
Gallina, G., Dolcetti, L., Serafini, P., Santo, C. D., Marigo, I., Colombo, M. P., Basso, G., Brombacher, F., Borrello, I., Zanovello, P., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28828 · Cited by 807
Adenosine, an endogenous distress signal, modulates tissue damage and repair
Fredholm, B. B. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402132 · Cited by 704
Sitkovsky, M. V., Lukashev, D. E., Apasov, S. G., Kojima, H., Koshiba, M., Caldwell, C. C., Ohta, A., & Thiel, M. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104731 · Cited by 697
ATP is a mediator of chemosensory transduction in the central nervous system
Gourine, A. V., Llaudet, E., Dale, N., & Spyer, K. M. (2005) · Nature · doi:10.1038/nature03690 · Cited by 537
Context, tissue plasticity, and cancer
Bissell, M. J., & LaBarge, M. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.12.013 · Cited by 517
Flagged first, then by citations
1 of the 28 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 670
Adenosine uptake is the major effector of extracellular ATP toxicity in human cervical cancer cells
Mello, P. D. A., Filippi‐Chiela, E. C., Nascimento, J., Beckenkamp, A., Santana, D. B., Kipper, F. C., Casali, É. A., Bruno, A. N., Paccez, J. D., Zerbini, L. F., et al. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-01-0042 · Cited by 66
Dexamethasone Enhances ATP-Induced Inflammatory Responses in Endothelial Cells
Ding, Y., Gao, Z., Jacobson, K. A., & Suffredini, A. F. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.171975 · Cited by 63
Real-time in vivo imaging of extracellular ATP in the brain with a hybrid-type fluorescent sensor
Kitajima, N., Takikawa, K., Sekiya, H., Satoh, K., Asanuma, D., Sakamoto, H., Takahashi, S., Hanaoka, K., Urano, Y., Namiki, S., et al. (2020) · eLife · doi:10.7554/elife.57544 · Cited by 59
Alvarez, C. L., Troncoso, M. F., & Espelt, M. V. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30580 · Cited by 59
Brock, V. J., Wolf, I. M. A., Er-Lukowiak, M., Lory, N. C., Stähler, T., Woelk, L.-M., Mittrücker, H., Müller, C. E., Koch‐Nolte, F., Rissiek, B., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl9770 · Cited by 59
Signalling by extracellular nucleotides in health and disease
Vultaggio-Poma, V., Falzoni, S., Salvi, G., Giuliani, A. L., & Virgilio, F. D. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119237 · Cited by 59
Braganhol, E., Kukulski, F., Lévesque, S. A., Fausther, M., Lavoie, É. G., Zanotto‐Filho, A., Bergamin, L. S., Pelletier, J., Bahrami, F., Yebdri, F. B., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.014 · Cited by 59
Schneider, G., Glaser, T., Lameu, C., Abdelbaset‐Ismail, A., Sellers, Z. P., Moniuszko, M., Ulrich, H., & Ratajczak, M. Z. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0469-z · Cited by 59
Qiu, Y., Liu, Y., Li, W.-H., Zhang, H., Tian, X., & Fang, W. (2017) · Oncology Reports · doi:10.3892/or.2017.6081 · Cited by 58
Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma
Zanoni, M., Sarti, A. C., Zamagni, A., Cortesi, M., Pignatta, S., Arienti, C., Tebaldi, M., Sarnelli, A., Romeo, A., Bartolini, D., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04526-0 · Cited by 62
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment
Serra, S., Vaisitti, T., Audrito, V., Bologna, C., Buonincontri, R., Chen, S., Arruga, F., Brusa, D., Coscia, M., Jakšić, O., et al. (2016) · Blood Advances · doi:10.1182/bloodadvances.2016000984 · Cited by 63
The pervasiveness of macropinocytosis in oncological malignancies
Commisso, C. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0153 · Cited by 57
ATP release during seizures – A critical evaluation of the evidence
Beamer, E. H., Conte, G., & Engel, T. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.12.021 · Cited by 62
P2X7 Receptor at the Crossroads of T Cell Fate
Rivas-Yáñez, E., Barrera‐Avalos, C., Parra-Tello, B., Briceño, P., Rosemblatt, M. V., Saavedra-Almarza, J., Rosemblatt, M. S., Acuña‐Castillo, C., Bono, M. R., & Sauma, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144937 · Cited by 62
Chouhan, S., Sawant, M., Weimholt, C., Luo, J. R., Sprung, R. W., Terrado, M., Mueller, D. M., Earp, H. S., & Mahajan, N. P. (2022) · Autophagy · doi:10.1080/15548627.2022.2103961 · Cited by 57
Davis, F. M., Kenny, P. A., Soo, E., van Denderen, B. J. W., Thompson, E. W., Cabot, P. J., Parat, M., Roberts‐Thomson, S. J., & Monteith, G. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023464 · Cited by 58
Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors
Chatterjee, S., Thyagarajan, K., Kesarwani, P., Song, J. H., Soloshchenko, M., Fu, J., Bailey, S. R., Vasu, C., Kraft, A. S., Paulos, C. M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1450 · Cited by 58
Yuan, Y. D., Du, C., Sun, C., Zhu, J., Wu, S., Zhang, Y., Ji, T., Lei, J., Yang, Y., Gao, N., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b04307 · Cited by 55
Sun, H., Li, L., Guo, R., Wang, Z., Guo, Y., Li, Z., & Song, F. (2023) · Chemical Science · doi:10.1039/d3sc05041f · Cited by 54
Abnormal expression of P2X family receptors in Chinese pediatric acute leukemias
Chong, J.-H., Zheng, G., Zhu, X., Guo, Y., Wang, L., Ma, C.-H., Liu, S., Xu, L., Lin, Y., & Wu, K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.087 · Cited by 54
P2 receptors in cancer progression and metastatic spreading
Virgilio, F. D., Falzoni, S., Giuliani, A. L., & Adinolfi, E. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.05.001 · Cited by 56
ATP‐P2Y2‐β‐catenin axis promotes cell invasion in breast cancer cells
Zhang, J., Liu, Y., Yang, H., Zhang, H., Tian, X., & Fang, W. (2017) · Cancer Science · doi:10.1111/cas.13273 · Cited by 54
Mello, P. D. A., Shu, B., Savio, L. E. B., Zhang, H., Zhang, J., JUNGER, W. G., Wink, M. R., Lenz, G., Buffon, A., Wu, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18595 · Cited by 57
Extracellular ATP signaling and clinical relevance
Dou, L., Chen, Y., Cowan, P. J., & Chen, X. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.12.006 · Cited by 54
Woods, L. T., Forti, K. M., Shanbhag, V., Camden, J. M., & Weisman, G. A. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114406 · Cited by 54
Purine and purinergic receptors in health and disease
Ai, Y., Wang, H., Liu, L., Qi, Y., Tang, S., Tang, J., & Chen, N. (2023) · MedComm · doi:10.1002/mco2.359 · Cited by 57
Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer
Drill, M., Jones, N. C., Hunn, M., O'Brien, T. J., & Monif, M. (2021) · Purinergic Signalling · doi:10.1007/s11302-021-09776-9 · Cited by 56
Stagg, J., Golden, E. B., Wennerberg, E., & Demaria, S. (2023) · Science Immunology · doi:10.1126/sciimmunol.abq3015 · Cited by 54
Nimodipine inhibits IL‐1β release stimulated by amyloid β from microglia
Sanz, J., Chiozzi, P., Colaianna, M., Zotti, M., Ferrari, D., Trabace, L., Zuliani, G., & Virgilio, F. D. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02112.x · Cited by 52
Dendritic cell altered states: what role for calcium?
Salter, R. D., & Watkins, S. C. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00806.x · Cited by 53
P2×7 targeting inhibits growth of human mesothelioma
Amoroso, F., Salaro, E., Falzoni, S., Chiozzi, P., Giuliani, A. L., Cavallesco, G. N., Maniscalco, P., Puozzo, A., Bononi, I., Martini, F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10430 · Cited by 51
Liu, Y., Geng, Y., Yang, H., Yang, H. K., Zhou, Y., Zhang, H., Tian, X., & Fang, W. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.043 · Cited by 51
Zhang, H., Steed, A., Co, M., & Chen, X. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2021.32 · Cited by 50
cGAMP the travelling messenger
Blest, H. T. W., & Chauveau, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1150705 · Cited by 57
Bergamin, L. S., Braganhol, E., Figueiró, F., Casali, É. A., Zanin, R. F., Sévigny, J., & Battastini, A. M. O. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25018 · Cited by 49
Adenosine Inhibits Tumor Cell Invasion via Receptor-Independent Mechanisms
Virtanen, S. S., Kukkonen-Macchi, A., Vainio, M., Elima, K., Härkönen, P. L., Jalkanen, S., & Yegutkin, G. G. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0302-t · Cited by 55
Ryoden, Y., Segawa, K., & Nagata, S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119286119 · Cited by 50
Extracellular ATP/adenosine dynamics in the brain and its role in health and disease
Shigetomi, E., Sakai, K., & Koizumi, S. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1343653 · Cited by 57
Elaskalani, O., Falasca, M., Moran, N. M., Berndt, M., & Metharom, P. (2017) · Cancers · doi:10.3390/cancers9100142 · Cited by 49
Duan, S., Nordmeier, S., Byrnes, A. E., & Buxton, I. L. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020597 · Cited by 48
Impact of the selective A2AR and A2BR dual antagonist AB928/etrumadenant on CAR T cell function
Seifert, M., Benmebarek, M.-R., Briukhovetska, D., Märkl, F., Dörr, J., Cadilha, B. L., Jobst, J., Stock, S., Andreu-Sanz, D., Lorenzini, T., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02013-z · Cited by 51
Martínez-Ramírez, A. S., Díaz‐Muñoz, M., Butanda-Ochoa, A., & Vázquez‐Cuevas, F. G. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9550-3 · Cited by 48
Singh, B., Modica-Napolitano, J. S., & Singh, K. K. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.004 · Cited by 49
The P2X7 Receptor as Regulator of T Cell Development and Function
Grassi, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01179 · Cited by 40
Farrell, A. W., Gadeock, S., Pupovac, A., Wang, B., Jalilian, I., Ranson, M., & Sluyter, R. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.07.001 · Cited by 47
Ledderose, C., Woehrle, T., Ledderose, S., Strasser, K., Seist, R., Bao, Y., Zhang, J., & JUNGER, W. G. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9510-y · Cited by 50
Jin, H., Ko, G. H., & Kim, H. J. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4552 · Cited by 48
Shaping of Dendritic Cell Function by the Metabolic Micro-Environment
Brombacher, E. C., & Everts, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00555 · Cited by 45
CD14 release induced by P2X7 receptor restricts inflammation and increases survival during sepsis
Alarcón‐Vila, C., Baroja‐Mazo, A., de Torre‐Minguela, C., Martínez, C. M., Martínez-García, J. J., Martínez‐Banaclocha, H., García-Palenciano, C., & Pelegrı́n, P. (2020) · eLife · doi:10.7554/elife.60849 · Cited by 48
The P2X7 Receptor in Tumor Immunity
Grassi, F., & Conti, B. D. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.694831 · Cited by 49
Maynard, J. P., Lee, J., Sohn, B. H., Yu, X., Lopez-Terrada, D. H., Finegold, M. J., Goss, J. A., & Thevananther, S. (2015) · Oncotarget · doi:10.18632/oncotarget.6240 · Cited by 46
Ratajczak, K., Łukasiak, A., Grel, H., Dworakowska, B., Jakieła, S., & Stobiecka, M. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-02061-0 · Cited by 46
ATP-Gated P2X7 Receptors Require Chloride Channels To Promote Inflammation in Human Macrophages
Janks, L., Sprague, R. S., & Egan, T. M. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801101 · Cited by 45
Zhao, H., Yan, L., Chen, J., Zhang, J., Yang, Q., Cui, J., Shi, A., & Wu, J. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.113758 · Cited by 45
Park, J., Williams, D. R., Lee, J., Lee, S., Lee, J., Ko, H., Lee, G.-E., Kim, S., Lee, J. M., Abdelrahman, A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01690 · Cited by 45
Fluorescence microscopy imaging of mitochondrial metabolism in cancer cells
Gooz, M. B., & Maldonado, E. N. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1152553 · Cited by 44
Martínez-Ramírez, A. S., Garay, E., García-Carrancá, A. M., & Vázquez‐Cuevas, F. G. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25390 · Cited by 44
Nazıroğlu, M., Blum, W., Jósvay, K., Çiğ, B., Henzi, T., Oláh, Z., Vízler, C., Schwaller, B., & Pecze, L. (2017) · Redox Biology · doi:10.1016/j.redox.2017.10.009 · Cited by 44
Vultaggio-Poma, V., Falzoni, S., Chiozzi, P., Sarti, A. C., Adinolfi, E., Giuliani, A. L., Sánchez-Melgar, A., Boldrini, P., Zanoni, M., Tesei, A., et al. (2021) · Theranostics · doi:10.7150/thno.66274 · Cited by 42
P2X7 receptor: a critical regulator and potential target for breast cancer
Zhu, X., Li, Q., Song, W., Peng, X., & Zhao, R. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02041-x · Cited by 43
Targeting extracellular Hsp90: A unique frontier against cancer
Sager, R., Khan, F. I., Toneatto, L., Votra, S. D., Backe, S. J., Woodford, M. R., Mollapour, M., & Bourboulia, D. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.982593 · Cited by 43
Measurement of purine release with microelectrode biosensors
Dale, N., & Frenguelli, B. G. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9273-4 · Cited by 43
ATP confers tumorigenic properties to dendritic cells by inducing amphiregulin secretion
Bles, N., di Pietrantonio, L., Boeynaems, J., & Communi, D. (2010) · Blood · doi:10.1182/blood-2010-01-265611 · Cited by 42
The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels
Giuliani, A. L., Berchan, M., Sanz, J. M., Passaro, A., Pizzicotti, S., Vultaggio-Poma, V., Sarti, A. C., & Virgilio, F. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00793 · Cited by 42
Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?
Benzaquen, J., Heeke, S., Hreich, S. J. D., Douguet, L., Marquette, C., Hofman, P. M., & Vouret‐Craviari, V. (2019) · Biomedical Journal · doi:10.1016/j.bj.2019.05.007 · Cited by 46
The P2X7 Receptor in Osteoarthritis
Li, Z., Huang, Z., & Bai, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.628330 · Cited by 42
Optical ATP biosensor for extracellular ATP measurement
Wang, C., Huang, C.-E., & Lin, W.-C. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2012.12.027 · Cited by 42
P2X7 Receptor Function in Bone-Related Cancer
Adinolfi, E., Amoroso, F., & Giuliani, A. L. (2012) · Journal of Osteoporosis · doi:10.1155/2012/637863 · Cited by 42
Bacterial Carriers for Glioblastoma Therapy
Mehta, N., Lyon, J. G., Patil, K., Mokarram, N., Kim, C. G., & Bellamkonda, R. V. (2016) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2016.12.003 · Cited by 41
Jin, H., & Kim, H. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093337 · Cited by 41
P2X receptors in cancer growth and progression
Virgilio, F. D., Vultaggio-Poma, V., & Sarti, A. C. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114350 · Cited by 43
The Purinergic System in Allotransplantation
Vergani, A., Tezza, S., Fotino, C., Visner, G. A., Pileggi, A., Chandraker, A. K., & Fiorina, P. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12567 · Cited by 40
Inhibitors of glucose transport and glycolysis as novel anticancer therapeutics
Qian, Y. (2014) · World Journal of Translational Medicine · doi:10.5528/wjtm.v3.i2.37 · Cited by 41
The P2X7 Receptor in the Maintenance of Cancer Stem Cells, Chemoresistance and Metastasis
Arnaud-Sampaio, V. F., Rabelo, I. L. A., Ulrich, H., & Lameu, C. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09936-w · Cited by 41
The Effect of the Tumor Microenvironment and Tumor-Derived Metabolites on Dendritic Cell Function
Lee, J., Choi, S.-Y., Jung, N.-C., Song, J. Y., Seo, H. G., Lee, H. S., & Lim, D. (2019) · Journal of Cancer · doi:10.7150/jca.38785 · Cited by 41
Fischer, A., Zhang, P., Ouyang, Y., Sohn, Y. S., Karmi, O., Nechushtai, R., Pikarsky, E., & Willner, I. (2022) · Small · doi:10.1002/smll.202204108 · Cited by 40
Müller, T., Fay, S., Vieira, R. P., Karmouty‐Quintana, H., Cicko, S., Ayata, C. K., Zissel, G., Goldmann, T., Lungarella, G., Ferrari, D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16414 · Cited by 39
Khalid, M., Brisson, L., Tariq, M., Hao, Y., Guibon, R., Fromont, G., Mortadza, S. A. S., Mousawi, F., Manzoor, S., Roger, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16191 · Cited by 39
Import of extracellular ATP in yeast and man modulates AMPK and TORC1 signalling
Forte, G. M. A., Davie, E., Lie, S., Franz‐Wachtel, M., Ovens, A. J., Wang, T., Oakhill, J. S., Maček, B., Hagan, I., & Petersen, J. (2019) · Journal of Cell Science · doi:10.1242/jcs.223925 · Cited by 39
In Vivo Detection of Extracellular Adenosine Triphosphate in a Mouse Model of Traumatic Brain Injury
Faroqi, A. H., Lim, M. J., Kee, E. C., Lee, J. H., Burgess, J. D., Chen, R., Virgilio, F. D., Delenclos, M., & McLean, P. J. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7226 · Cited by 39
P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer
Maynard, J. P., Lu, J., Vidal, I., Hicks, J. L., Mummert, L. A., Ali, T., Kempski, R., Carter, A. M., Sosa, R. Y., Peiffer, L. B., et al. (2021) · The Journal of Pathology · doi:10.1002/path.5815 · Cited by 39
P2X receptors: New players in cancer pain
Franceschini, A. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i4.429 · Cited by 39
Burghoff, S., Gong, X., Viethen, C., Jacoby, C., Flögel, U., Bongardt, S., Schorr, A., Hippe, A., Homey, B., & Schrader, J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-898 · Cited by 39
Intelligent Delivery Systems in Tumor Metabolism Regulation: Exploring the Path Ahead
Li, X., Sun, T., & Jiang, C. (2023) · Advanced Materials · doi:10.1002/adma.202309582 · Cited by 38
Díaz-Pérez, J. A., Killeen, M. E., Yang, Y., Carey, C. D., Falo, L. D., & Mathers, A. R. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.05.018 · Cited by 37
Adenosine and adenosine receptors in colorectal cancer
Hajizadeh, F., Masjedi, A., Asl, S. H., Kiani, F. K., Peydaveisi, M., Ghalamfarsa, G., Jadidi‐Niaragh, F., & Севбитов, А. В. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106853 · Cited by 41
Cell‐surface sensors: lighting the cellular environment
Ali, M. M., Kang, D., Tsang, K., Fu, M., Karp, J. M., & Zhao, W. (2012) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1179 · Cited by 38
Ectonucleotidases in Tumor Cells and Tumor-Associated Immune Cells: An Overview
Bergamin, L. S., Braganhol, E., Zanin, R. F., Edelweiss, M. I. A., & Battastini, A. M. O. (2012) · BioMed Research International · doi:10.1155/2012/959848 · Cited by 38
Assessing Extracellular ATP as Danger Signal In Vivo: The pmeLuc System
Virgilio, F. D., Pinton, P., & Falzoni, S. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3566-6_7 · Cited by 38
Kwon, S. G., Roh, D., Yoon, S. Y., Moon, J.-Y., Choi, S., Choi, H., Kang, S.-Y., Han, H. J., Beitz, A. J., Oh, S. B., et al. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-2 · Cited by 37
P2RX7B is a new theranostic marker for lung adenocarcinoma patients
Benzaquen, J., Hreich, S. J. D., Heeke, S., Juhel, T., Lalvée, S., Bauwens, S., Saccani, S., Lenormand, P., Hofman, V., Butori, M., et al. (2020) · Theranostics · doi:10.7150/thno.48229 · Cited by 39
Intracellular Transport in Cancer Metabolic Reprogramming
Sneeggen, M., Guadagno, N. A., & Progida, C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.597608 · Cited by 39
Bueschbell, B., Caniceiro, A. B., Suzano, P. M. S., Machuqueiro, M., Rosário‐Ferreira, N., & Moreira, I. S. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100811 · Cited by 38
Why myotoxin-containing snake venoms possess powerful nucleotidases?
Caccin, P., Pellegatti, P., Fernández, J., Vono, M., Cintra‐Francischinelli, M., Lomonte, B., Gutiérrez, J. M., Virgilio, F. D., & Montecucco, C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.11.129 · Cited by 36
Self-citationWang, X., Li, L., Guan, R., Zhu, D., Song, N., & Shen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485495 · Cited by 36
The role of microglia and P2X7 receptors in gliomas
Kan, L. K., Williams, D. J., Drummond, K. J., O'Brien, T. J., & Monif, M. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.04.010 · Cited by 37
Role of the P2X7 receptor in in vitro and in vivo glioma tumor growth
Bergamin, L. S., Capece, M., Salaro, E., Sarti, A. C., Falzoni, S., Pereira, M. S. L., Bastiani, M. A. D., Scholl, J. N., Battastini, A. M. O., & Virgilio, F. D. (2019) · Oncotarget · doi:10.18632/oncotarget.27106 · Cited by 36
Wang, X., Chen, X., Chu, C., Deng, Y., Yang, M. J., Ji, Z., Xu, F., Huo, D., Luo, Y., & Hou, C. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.128653 · Cited by 36
The P2X7 purinergic receptor: a potential therapeutic target for lung cancer
Li, Q., Zhu, X., Song, W., Peng, X., & Zhao, R. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03379-4 · Cited by 36
Purinergic signaling: Diverse effects and therapeutic potential in cancer
Kaur, J., & Dora, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1058371 · Cited by 36
Metadata
- Authors
- Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V., & Di Virgilio, F.
- Affiliations
- University of Ferrara (IT)
- Istituto Giannina Gaslini (IT)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-07-09
- Volume
- 3
- Issue
- 7
- Pages
- e2599
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2440522
- OpenAlex
- W2070663123
- Cited by
- 668
- References
- 28
- Citations by year
- 2026: 31 · 2025: 40 · 2024: 29 · 2023: 62 · 2022: 51 · 2021: 58 · 2020: 66 · 2019: 42 · 2018: 37 · 2017: 34 · 2016: 33 · 2015: 25 · 2014: 36 · 2013: 28 · 2012: 40
- FWCI
- 11.40
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Funders
- Fondazione Italiana per la Lotta al Neuroblastoma
- Associazione Italiana per la Ricerca sul Cancro (GGP06070)
- Università degli Studi di Ferrara
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › bioluminescence and chemiluminescence research
- Keywords
- extracellular ATP, tumor microenvironment, in vivo imaging, adenosine, adenosine A2A receptor, immunosuppression, ATP catabolism, adenosine transporter
- MeSH terms
- Adenosine Triphosphate, Animals, Cell Membrane, Extracellular Space, Humans, Luciferases, Luminescent Measurements, Mice, Nude, Neoplasms, Cell Line, Tumor, Luminescent Agents, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review